Filter
1154
Text search:
hiv-infected
children
Featured
114
371
Language
Document type
863
121
82
35
22
12
8
4
3
1
1
1
Countries / Regions
78
58
52
47
35
32
32
30
29
27
20
18
17
16
14
13
13
12
12
11
10
10
10
9
8
8
7
6
6
6
6
5
5
5
5
5
4
4
4
3
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
551
114
64
51
37
17
8
Toolboxes
240
194
20
19
16
10
10
9
9
9
8
7
7
6
5
3
3
2
2
2
1
1
1
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
WHO recommendations on newborn health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)? ...
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)? ...
(updated December 2014).
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
NHSP 2017- 2022 (Final draft)
A manual for programme managers.
БОРЬБА С ТУБЕРКУЛЕЗОМ В ТЮРЬМАХ
Руководство для руководителей программ
Scientific advice
Prevention and control of communicable diseases in prison settings.
Federal Bureau of Prisons
Clinical Practice Guidelines
January 1010
Stop TB Communicable Diseases
treat TB
Description of Research Outputs, 2009 - 2014
Update 2021; Immunization, Vaccines and Biologicals
Emerging Infectious Diseases; Vol. 21, No. 11, November 2015
Interferon-γ Assays - Description and Assessment of a New Tool in the Diagnosis of Tuberculosis.
Haür B et al. Interferon-γ-Tests in der ...Pneumologie 2006; 60: 29-44
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.